MKRN3 mutations in familial central precocious puberty

Hormone Research in Paediatrics

Volumn 82, Issue 2, 2014, Pages 122-126

  Schreiner, Felix ^a   Gohlke, Bettina ^a   Hamm, Michaela ^a   Korsch, Eckhard ^b   Woelfle, Joachim ^a  

^a UNIVERSITY OF BONN   (Germany)

^b Childre s Hospital Amsterdamer Straße   (Germany)

Author keywords

Familial central precocious puberty; Makorin RING finger protein 3; MKRN3 mutations

Indexed keywords

GENOMIC DNA; GONADORELIN; LUTEINIZING HORMONE; MKRN3 PROTEIN, HUMAN; RIBONUCLEOPROTEIN; STOP CODON;

ADRENAL CORTEX ADENOMA; ARTICLE; BLOOD SAMPLING; BODY HEIGHT; CHILD; CLINICAL ARTICLE; FAMILIAL CENTRAL PRECOCIOUS PUBERTY; FAMILIAL DISEASE; FEMALE; FRAMESHIFT MUTATION; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC SCREENING; GROWTH ACCELERATION; HETEROZYGOTE; HUMAN; HYPERANDROGENISM; INHERITANCE; LOSS OF FUNCTION MUTATION; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MKRN3 GENE; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; SCHOOL CHILD; STOP CODON; ALLELE; COHORT ANALYSIS; GENETIC DISORDER; GENETICS;

ALLELES; CHILD; CODON, TERMINATOR; COHORT STUDIES; FEMALE; FRAMESHIFT MUTATION; GENETIC DISEASES, INBORN; HUMANS; MALE; PUBERTY, PRECOCIOUS; RIBONUCLEOPROTEINS;

EID: 84928168409     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000362815     Document Type: Article

References (31)

1. Treloar SA, Martin NG: Age at menarche as a fitness trait: nonadditive genetic variance detected in a large twin sample. Am J Hum Genet 1990; 47: 137-148.
2. Hauspie RC, Vercauteren M, Susanne C: Secular changes in growth and maturation: an update. Acta Paediatr Suppl 1997; 423: 20-27.
3. De Muinich Keizer SM, Mul D: Trends in pubertal development in Europe. Hum Reprod Update 2001; 7: 287-291.
4. Gohlke B, Woelfle J: Growth and puberty in German children: is there still a positive secular trend? Dtsch Arztebl Int 2009; 106: 377-382.
5. Anderson CA, Zhu G, Falchi M, van den Berg SM, Treloar SA, Spector TD, Martin NG, Boomsma DI, Visscher PM, Montgomery GW: A genome-wide linkage scan for age at menarche in three populations of European descent. J Clin Endocrinol Metab 2008; 93: 3965-3970.
6. Elks CE, Perry JR, Sulem P, Chasman DI, Franceschini N, He C, et al: Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. Nat Genet 2010; 42: 1077-1085.
7. Fernández-Rhodes L, Demerath EW, Cousminer DL, Tao R, Dreyfus JG, Esko T, et al: Association of adiposity genetic variants with menarche timing in 92,105 women of European descent. Am J Epidemiol 2013; 178: 451-460.
8. De Vries L, Kauschansky A, Shohat M, Phillip M: Familial central precocious puberty suggests autosomal dominant inheritance. J Clin Endocrinol Metab 2004; 89: 1794-1800.
9. Teles MG, Bianco SD, Brito VN, Trarbach EB, Kuohung W, Xu S, Seminara SB, Mendonca BB, Kaiser UB, Latronico AC: A GPR54-activating mutation in a patient with central precocious puberty. N Engl J Med 2008; 358: 709-715.
10. Silveira LG, Noel SD, Silveira-Neto AP, Abreu AP, Brito VN, Santos MG, Bianco SD, Kuohung W, Xu S, Gryngarten M, Escobar ME, Arnhold IJ, Mendonca BB, Kaiser UB, Latronico AC: Mutations of the KISS1 gene in disorders of puberty. J Clin Endocrinol Metab 2010; 95: 2276-2280.
11. Topaloglu AK, Reimann R, Gluclu M, Yalin AS, Kotan LD, Porter KM, Serin A, Mungan NO, Cook JR, Ozbek MN, Imamoglu S, Akalin NS, Yuksel B, O'Rahilly S, Semple RK: TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for neurokinin B in the central control of reproduction. Nat Genet 2009; 41: 354-358.
12. Topaloglu AK, Tello JA, Kotan LD, Ozbek MN, Yilmaz MB, Erdogan S, Gurbuz F, Temiz F, Millar RP, Yuksel B: Inactivating KISS1 mutation and hypogonadotropic hypogonadism. N Engl J Med 2012; 366: 629-635.
13. Abreu AP, Dauber A, Macedo DB, Noel SD, Brito VN, Gill JC, Cukier P, Thompson IR, Navarro VM, Gagliardi PC, Rodrigues T, Kochi C, Longui CA, Beckers D, de Zegher F, Montenegro LR, Mendonca BB, Carroll RS, Hirschhorn JN, Latronico AC, Kaiser UB: Central precocious puberty caused by mutations in the imprinted gene MKRN3. N Engl J Med 2013; 368: 2467-2475.
14. Partsch CJ, Hümmelink R, Sippell WG: Reference ranges for lutropin and follitropin in the luliberin test in prepubertal and pubertal children using a monoclonal immunoradiometric assay. J Clin Chem Clin Biochem 1990; 28: 49-52.
15. Bona G, Marinello D: Precocious puberty in immigrant children: indications for treatment. J Pediatr Endocrinol Metab 2000; 13(suppl 1):831-834.
16. Mul D, Oostdijk W, Drop SL: Early puberty in adopted children. Horm Res 2002; 57: 1-9.
17. Parent AS, Teilmann G, Juul A, Skakkebaek NE, Toppari J, Bourguignon JP: The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration. Endocr Rev 2003; 24: 668-693.
18. Zachmann M, Prader A, Kind HP, Häfliger H, Budliger H: Testicular volume during adolescence. Cross-sectional and longitudinal studies. Helv Paediatr Acta 1974; 29: 61-72.
19. Settas N, Dacou-Voutetakis C, Karantza M, Kanaka-Gantenbein C, Chrousos GP, Voutetakis A: Central precocious puberty in a girl and early puberty in her brother caused by a novel mutation in the MKRN3 gene. J Clin Endocrinol Metab 2014; 99: E647-E651.
20. Hsu YH, Kiel DP: Clinical review: Genomewide association studies of skeletal phenotypes: what we have learned and where we are headed. J Clin Endocrinol Metab 2012; 97: E1958-E1977.
21. Ran S, Pei YF, Liu YJ, Zhang L, Han YY, Hai R, Tian Q, Lin Y, Yang TL, Guo YF, Shen H, Thethi IS, Zhu XZ, Deng HW: Bivariate genome- wide association analyses identified genes with pleiotropic effects for femoral neck bone geometry and age at menarche. PLoS One 2013; 8:e60362.
22. Gurrieri F, Accadia M: Genetic imprinting: the paradigm of Prader-Willi and Angelman syndromes. Endocr Dev 2009; 14: 20-28.
23. Smith A, Marks R, Haan E, Dixon J, Trent RJ: Clinical features in four patients with Angelman syndrome resulting from paternal uniparental disomy. J Med Genet 1997; 34: 426-429.
24. Clayton-Smith J, Laan L: Angelman syndrome: a review of the clinical and genetic aspects. J Med Genet 2003; 40: 87-95.
25. Gross-Tsur V, Hirsch HJ, Benarroch F, Eldar- Geva T: The FSH-inhibin axis in Prader- Willi syndrome: heterogeneity of gonadal dysfunction. Reprod Biol Endocrinol 2012; 10: 39.
26. Radicioni AF, Di Giorgio G, Grugni G, Cuttini M, Losacco V, Anzuini A, Spera S, Marzano C, Lenzi A, Cappa M, Crinò A: Multiple forms of hypogonadism of central, peripheral or combined origin in males with Prader-Willi syndrome. Clin Endocrinol (Oxf) 2012; 76: 72-77.
27. Kanber D, Giltay J, Wieczorek D, Zogel C, Hochstenbach R, Caliebe A, Kuechler A, Horsthemke B, Buiting K: A paternal deletion of MKRN3, MAGEL2 and NDN does not result in Prader-Willi syndrome. Eur J Hum Genet 2009; 17: 582-590.
28. Crinò A, Schiaffini R, Ciampalini P, Spera S, Beccaria L, Benzi F, Bosio L, Corrias A, Gargantini L, Salvatoni A, Tonini G, Trifirò G, Livieri C; Genetic Obesity Study Group of Italian Society of Pediatric endocrinology and Diabetology (SIEDP): Hypogonadism and pubertal development in Prader-Willi syndrome. Eur J Pediatr 2003; 162: 327-333.
29. Pusz ER, Rotenstein D: Treatment of precocious puberty in a female with Prader-Willi syndrome. J Pediatr Endocrinol Metab 2008; 21: 495-500.
30. Lee HS, Hwang JS: Central precocious puberty in a girl with Prader-Willi syndrome. J Pediatr Endocrinol Metab 2013; 26: 1201-1204.
31. Whittington J, Holland T: Prader-Willi Syndrome: Development and Manifestations. Cambridge, Cambridge University Press, 2004.